Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Diego Mesa Puyo selected as next GEF CEO and Chairperson

    August 5, 2026

    Envision and Sasol Advance Future Energy Systems with Green Hydrogen Collaboration in South Africa

    August 5, 2026

    Factory Output in the Eurozone Reaches 52-Month Peak Amidst Sluggish Demand, Growth Outpaces Orders

    August 5, 2026
    Facebook X (Twitter) Instagram
    Quds Times: Jerusalem and Palestine, in context.Quds Times: Jerusalem and Palestine, in context.
    • Home
    • Contact Us
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    Quds Times: Jerusalem and Palestine, in context.Quds Times: Jerusalem and Palestine, in context.
    Home » ZeptoMetrix Launches PROtrol: Quality Control Material for the Lateral Flow Immunoassay Market
    Featured News

    ZeptoMetrix Launches PROtrol: Quality Control Material for the Lateral Flow Immunoassay Market

    May 18, 2023
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Telegram Email

    BUFFALO, NY / ACCESSWIRE / May 16, 2023 / ZeptoMetrix® is excited to introduce PROtrol TM, a new line of products designed for antigen-based diagnostic methods. These third-party materials mimic a true clinical specimen and can be used to evaluate and monitor the performance of antigen-based assays, including lateral flow immunoassays for infectious diseases.

    ZeptoMetrix logo
    ZeptoMetrix logo

    PROtrol is the only whole organism reference material to provide complete testing data. Each lot of product is supplied with the protein concentration and TCID50 value, which minimizes qualification testing. PROtrol provides better reproducibility, which optimizes the use of financial spending and processing time through the decreased need for repeat testing.

    “The rapid expansion in development of antigen-based assays has highlighted some quality challenges. Inactivated, whole organism controls designed specifically for antigen tests can equip manufacturers with the tools they need to better evaluate the performance of their assays, leading to higher quality tests on the market,” said Dr. Karuna Sharma, Vice President & Chief Scientific Officer.

    PROtrol SARS-Related Coronavirus 2 (SARS-CoV-2) Isolate: USA-WA1/2020* is the first member of this product line (PROSARS(COV2)-587). As we move beyond the COVID-19 pandemic, ZeptoMetrix will continue to grow the PROtrol product line, providing high-quality controls to assay manufacturers seeking to expand access to inexpensive and easy-to-use diagnostics.

    “The launch and expansion of PROtrol enhances our position as the partner of choice for diagnostic test developers,” said Evangeline Gonzalez, President of Antylia Diagnostics division. “As we work with our diagnostic partners, ZeptoMetrix is pleased with the role that PROtrol plays to give patients around the world more access to diagnostic testing.”

    More information on how to order the new PROtrol and additional ZeptoMetrix products can be found at: https://www.zeptometrix.com

    About ZeptoMetrix®
    ZeptoMetrix® is an established industry leader in the design, development, and delivery of innovative, quality solutions to the infectious disease diagnostics market. Our expertise and abilities in molecular diagnostics, including external quality controls, verification panels, proficiency panels, customized and OEM products/services have set the industry standard for performance and reliability and make ZeptoMetrix the preferred choice for independent third-party quality control materials.

    Links:
    * (PROSARS(COV2)-587): product page
    https://www.zeptometrix.com/products/protrolt-sars-cov-2-isolate-usa-wa1-2020-1-ml

    Contact Information

    Andrew Zenger
    Global Product Manager
    andrew.zenger@antylia.com
    (716) 715-7417

    Related Files

    PROSARS(COV2)-587 Product Insert.pdf
    ZeptoMetrix Launches PROtrol.pdf

    SOURCE: ZeptoMetrix

    .

    ZeptoMetrix Launches PROtrol: Quality Control Material for the Lateral Flow Immunoassay Market

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Related Posts

    Dubai Delhi AI4306 delay exposes Air India crisis management

    August 4, 2026

    Dun & Bradstreet SAME Brings Dun & Bradstreet, Anthropic Collaboration to Local Markets, Transforming AI-Driven Compliance Through Claude

    July 22, 2026

    Fynd Launches ‘Fynd Create’ in GCC, an AI-Native Platform for Fashion Design, Sourcing and Production

    July 15, 2026

    Truecaller Ads Launches ‘Call-to-Cart’, a New Commerce Surface Built on the Communication Layer

    June 17, 2026

    Al Naboodah Opens GWM’s Largest Overseas Showroom in the UAE

    June 16, 2026

    JustMarkets Research Highlights Global Growth Divergence as a Key Market Driver

    June 4, 2026
    Latest News
    Business

    Factory Output in the Eurozone Reaches 52-Month Peak Amidst Sluggish Demand, Growth Outpaces Orders

    August 5, 2026

    Eurozone manufacturing output accelerated in July while new orders and exports stayed weak. The survey’s output index climbed from 51.7 to 52.9, reaching a level not seen since March 2022. While production growth outpaced the overall manufacturing index, companies relied heavily on orders accumulated in previous months. The increase in new orders was marginal and lagged behind production growth. Export orders declined once again, with decreases in France, Spain, Italy, and Austria outweighing gains elsewhere within the euro area.

    Scaleup Europe Fund Launches with €5 Billion Goal, EU Sets Strategic Investment Initiative

    August 5, 2026

    WTO Emphasizes Inclusive AI Policies During Trade and Technology Event, Highlighting Global Commerce Opportunities

    August 5, 2026

    OECD inflation eases to 4.2%, as energy prices contribute to slowdown

    August 5, 2026

    Fuego Volcano Eruption Triggers Critical Alert in Guatemala, Evacuations Underway

    August 5, 2026

    Ebola Vaccine Trials Get Underway with Moderna and Oxford, Amid Ongoing DR Congo Outbreak

    August 5, 2026

    New EU Rules for AI Content Labeling Implemented, Compliance Enforced

    August 4, 2026

    UK Economic Stability Maintained, Despite Rising Inflation and Employment Challenges

    August 4, 2026
    © 2026 Quds Times | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.